<HashMap><database>biostudies-literature</database><scores/><additional><submitter>McLean CP</submitter><funding>RRD VA</funding><funding>U.S. Department of Defense</funding><funding>VA</funding><funding>U.S. Department of Veterans Affairs</funding><pagination>1792-1800</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9538243</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>35(6)</volume><pubmed_abstract>Trauma-exposed veterans receiving mental health care may have an elevated risk of experiencing COVID-19-related difficulties. Using data from several ongoing clinical trials (N = 458), this study examined exposure to COVID-19-related stressors and their associations with key sociodemographic factors and mental health outcomes. The results showed that exposure to COVID-19-related stressors was common, higher among veterans who were racial/ethnic minorities d = 0.32, and associated with elevated posttraumatic stress disorder (PTSD), r = .288, and depressive symptom severity, r = .246. Women veterans experienced more difficulty accessing social support, d = 0.31, and higher levels of COVID-19-related distress, d = 0.31, than men. Qualitative data were consistent with survey findings and highlighted the broader societal context in veterans' experience of COVID-19-related distress. These findings may inform future research on the impact of the pandemic on veterans, particularly those who are women and members of minoritized racial/ethnic groups, as well as mental health treatment planning for this population.</pubmed_abstract><journal>Journal of traumatic stress</journal><pubmed_title>The mental health impact of COVID-19-related stressors among treatment-seeking trauma-exposed veterans.</pubmed_title><pmcid>PMC9538243</pmcid><funding_grant_id>I01 RX002412</funding_grant_id><funding_grant_id>W81XWH‐15‐1‐0330</funding_grant_id><funding_grant_id>I01RX002412-01A1</funding_grant_id><funding_grant_id>IIR 16-070</funding_grant_id><funding_grant_id>I01RX002412‐01A1</funding_grant_id><funding_grant_id>I01RX002093‐01</funding_grant_id><funding_grant_id>IIR 16‐070</funding_grant_id><funding_grant_id>I01 RX002093</funding_grant_id><funding_grant_id>I01RX002093-01</funding_grant_id><pubmed_authors>Wachsman T</pubmed_authors><pubmed_authors>Cloitre M</pubmed_authors><pubmed_authors>Morland L</pubmed_authors><pubmed_authors>McLean CP</pubmed_authors><pubmed_authors>Hooper V</pubmed_authors><pubmed_authors>Norman SB</pubmed_authors></additional><is_claimable>false</is_claimable><name>The mental health impact of COVID-19-related stressors among treatment-seeking trauma-exposed veterans.</name><description>Trauma-exposed veterans receiving mental health care may have an elevated risk of experiencing COVID-19-related difficulties. Using data from several ongoing clinical trials (N = 458), this study examined exposure to COVID-19-related stressors and their associations with key sociodemographic factors and mental health outcomes. The results showed that exposure to COVID-19-related stressors was common, higher among veterans who were racial/ethnic minorities d = 0.32, and associated with elevated posttraumatic stress disorder (PTSD), r = .288, and depressive symptom severity, r = .246. Women veterans experienced more difficulty accessing social support, d = 0.31, and higher levels of COVID-19-related distress, d = 0.31, than men. Qualitative data were consistent with survey findings and highlighted the broader societal context in veterans' experience of COVID-19-related distress. These findings may inform future research on the impact of the pandemic on veterans, particularly those who are women and members of minoritized racial/ethnic groups, as well as mental health treatment planning for this population.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-04T22:33:41.277Z</modification><creation>2025-02-19T03:22:58.904Z</creation></dates><accession>S-EPMC9538243</accession><cross_references><pubmed>36065487</pubmed><doi>10.1002/jts.22874</doi></cross_references></HashMap>